Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 9/20 | 0.35 |
| ▸ | CDK2 | P24941 | 9/20 | 0.35 |
| ▸ | KDR | P35968 | 6/20 | 0.34 |
| ▸ | OGA | O60502 | 2/20 | 0.33 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23314218 | 0.83 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL24499305 | 0.72 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL24499289 | 0.69 | — | — | |
| SCHEMBL24899642 | 0.69 | APLNR (0.34) | CDK1CDK2KDROGA | |
| SCHEMBL1698272 | 0.67 | LMNA (0.36) | ALDH1A1 | |
| SCHEMBL24499838 | 0.67 | KDM4E (0.33) | — | |
| SCHEMBL24499299 | 0.67 | KDM4E (0.33) | — | |
| SCHEMBL24499833 | 0.67 | APLNR (0.35) | ALDH1A1 | |
| SCHEMBL24499866 | 0.67 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL24899728 | 0.65 | CDK1 (0.35) | CDK1CDK2KDROGADRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220177470-A1 | SULFOXIMINE GLYCOSIDASE INHIBITORS | ASCENEURON SA (CH) | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220177470-A1 | SULFOXIMINE GLYCOSIDASE INHIBITORS | ENGASE, BACE1, GAA | CDK1 2189/4885CDK2 2862/4885KDR 4522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.